Artisan Acquisition Corp. Warrant -26.03.26 on Artisan Acquisition PRENW 深 沪
交易中 09-11 10:39:21 美东时间
0.0129
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0129
- 总市值 0
- 52周最高 0.038
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.0081
- 委 比 -97.87%
- 总股本 --
- 历史最高 0.636
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.00
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Prenetics Global CEO and CFO purchase $1M of shares in open market
Prenetics Global (PRE) announced on Wednesday that Danny Yeung, chief executive officer, and Brian Rosin, chief financial officer, completed open market purchases of its ordinary shares during the pe...
08-26 20:57
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Prenetics reported Q2 2026 revenue of $46.5 million, up 288% YoY, with IM8 contributing $45 million, up 359% YoY. July marked IM8's strongest month at $20.9 million, annualizing to $251 million. The company raised FY2026 revenue guidance to $220-$230 million and initiated FY2027 IM8 guidance of $400 million+. CEO Danny Yeung highlighted the sixth consecutive record quarter, positive Adjusted Free Cash Flow, and a new reporting approach with detai...
08-18 11:30
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
IM8, the fastest-growing premium supplement brand, has delivered over 50 million servings and sees an order every 27 seconds. Prenetics raised its 2026 revenue guidance to $210–220 million and expects $300 million by year-end 2026, with $400 million+ in 2027. Every $1 in customer acquisition returns $1.44 in gross profit. Prenetics secured $1 billion in growth financing from General Catalyst's Customer Value Fund to scale marketing without diluti...
07-14 17:35
Prenetics posts revenue growth, lifts 2026 outlook
Prenetics Global (PRE) on Wednesday reported first-quarter revenue of $36M and raised its 2026 IM8 revenue forecast to $190M-$210M from $180M-$200M, citing strong demand for its health supplements bra...
06-10 22:39
NewGenIVF Enters Strategic Agreement With K25.ai For A $2M Investment At A Valuation Of $100M
NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGenIVF" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an
05-21 20:33
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
Prenetics Global Limited announced a multi-year global partnership with Jay Shetty, who becomes IM8’s first global ambassador from outside the sports world and a shareholder in Prenetics. Shetty, a bestselling author and podcast host, has been using IM8 Daily Ultimate Essentials for nearly a year and believes in the brand. IM8, a premium health and longevity brand co-founded with David Beckham, reported Q1 2026 revenue of $33.8 million, nearly 6x...
05-20 12:00
Prenetics Global Reports Q1 2026 Results: Full Earnings Call Transcript
Prenetics Global (NASDAQ:PRE) held its first-quarter earnings conference call o...
05-14 21:17
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
Prenetics旗下IM8与Superpower达成战略伙伴关系，联手打造首个闭环健康系统，将临床级营养补充与精准血检结合。IM8订阅用户可享75%折扣购买Superpower血检服务，实现补充剂效果可测。双方合作旨在填补健康行业空白，提供个性化数据驱动的健康管理方案。
03-24 15:00
